PrimeRFP SCOUT · Federal Contract Recompete Brief · GSA MAS

75F40122F80395ONE (1) EACH upright and inverted — Vwr International, LLC

Vwr International, LLC holds $30.6M across 31,467 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent GS07F119CA. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Nov 14, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs

Awarding office

Vwr International, LLC

Recipient

Nov 14, 2022

PoP end

$130K

Obligated

$130K

Potential

339113

NAICS

6640

PSC

GSA MAS

Vehicle

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Vwr International, LLC — $90

Contract facts

Federal

Contract number75F40122F80395

Also listed asGS07F119CA-75F40122F80395

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentVwr International, LLC

CAGE01MX7

UEIJ6CNECEBTK23

NAICS339113

No full NAICS 339113 intel page yet. Browse NAICS intelligence

PSC6640

VehicleGSA MAS

Parent IDIQ / IDVGS07F119CA

Place of performanceWAYNE PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 15, 2022

PoP end (current)Nov 14, 2022

Obligated$130K

Current value$130K

Potential value$130K

ONE (1) EACH UPRIGHT AND INVERTED HYBRID MICROSCOPE is a federal award for Fda Office Of Acq Grant Svcs held by Vwr International, LLC. Estimated value $130K ($130K obligated). Current period of performance ends Nov 14, 2022. Last award drew 1 bidder. Place of performance: WAYNE PA.

ONE (1) EACH UPRIGHT AND INVERTED HYBRID MICROSCOPE

Recompete timing

Public

● Past PoP end (1376 days ago)

Current PoP ended Nov 14, 2022 (1376 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Vwr International, LLC — $30.6M obligated across 31,467 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($30.6M) · all agencies · Top 4 shown (98%); remaining ~2% is other agencies.

Department of Defense (DOD)$24.1M · 79%Department of Health and Human Services (HHS)$4.3M · 14%Department of Agriculture (USDA)$1.2M · 4%Department of Veterans Affairs (VA)$470K · 2%

Open full company profile →

Related awards

Same parent · incumbent

75N90025P00752

ORSC CGMP CLEANING SUPPLIES FROM VWR INTERNATIONAL:1110027 [25-010337]

$250K

Sep 21, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40122F80395?

75F40122F80395 (ONE (1) EACH upright and inverted) is a Fda Office Of Acq Grant Svcs award with a potential value of $130K, currently held by Vwr International, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40122F80395?

Fda Office Of Acq Grant Svcs awarded 75F40122F80395 to Vwr International, LLC (potential $130K).

Who is the incumbent on 75F40122F80395?

Vwr International, LLC is the incumbent with $30.6M across 31467 related awards in SCOUT’s public footprint. The current period of performance ends Nov 14, 2022.

When does Vwr International, LLC’s 75F40122F80395 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 14, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 15, 2022